We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-6.1%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$13.5M
AUM Growth
-$1.55M
Cap. Flow
+$17.1M
Cap. Flow %
126.71%
Top 10 Hldgs %
54.64%
Holding
84
New
22
Increased
18
Reduced
8
Closed
28

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$801K
2
WEAV icon
Weave Communications
WEAV
+$715K
3
VKTX icon
Viking Therapeutics
VKTX
+$662K
4
SRG
Seritage Growth Properties
SRG
+$385K
5
ML
MoneyLion Inc.
ML
+$305K

Top Sells

Rank Stock Value
1
AIP icon
Arteris
AIP
+$1.01M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$908K
3
INSM icon
Insmed
INSM
+$597K
4
APLS
Apellis Pharmaceuticals
APLS
+$453K
5
NVO
Novo Nordisk
NVO
+$385K

Sector Composition

Rank Sector Weight
1 Healthcare 30.58%
2 Real Estate 24.99%
3 Technology 20.99%
4 Communication Services 7.7%
5 Financials 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QURE icon
76
uniQure
QURE
$3.02B
– –
-34,300
Closed -$167K
SCPH
77
DELISTED
scPharmaceuticals
SCPH
– –
-2,283
Closed -$11.5K
SRPT icon
78
CALL
Sarepta Therapeutics
SRPT
$1.59B
– –
-70,600
Closed -$417K
TELA icon
79
TELA Bio
TELA
$33.7M
– –
-3,860
Closed -$21.9K
TLS icon
80
Telos
TLS
$329M
– –
-12,500
Closed -$52K
XNTK icon
81
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
– –
-15,400
Closed -$14.8K
ITCI
82
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-3,300
Closed -$228K
INFN
83
DELISTED
Infinera Corporation Common Stock
INFN
– –
-17,758
Closed -$107K
AUGX
84
DELISTED
Augmedix, Inc. Common Stock
AUGX
– –
-13,632
Closed -$55.8K
1 2 3
4

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM

Worth Venture Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Worth Venture Partners held 84 positions worth $13.5M, down 10% from $15M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Worth Venture Partners deployed $17.1M of net new capital in Q2 2024, opening 22 new positions and adding to 18 existing holdings. Its largest new stake was Pfizer: 29,100 shares worth $814K.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Innovid Corp., an estimated $64.2K trimmed.

  • Worth Venture Partners's largest Q2 2024 buy was Pfizer: 29,100 shares worth $814K.
  • Worth Venture Partners added most to Weave Communications in Q2 2024, an estimated $715K increase.
  • Worth Venture Partners's biggest Q2 2024 reduction was Innovid Corp., cutting an estimated $64.2K.
  • Worth Venture Partners fully exited Arteris in Q2 2024, selling an estimated $1.01M.
  • Worth Venture Partners's ten largest holdings make up 55% of its $13.5M portfolio in Q2 2024.
  • Worth Venture Partners opened 22 new positions and closed 28 in Q2 2024.
  • Worth Venture Partners's portfolio value fell 10% quarter-over-quarter to $13.5M.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.